Gabriel A Bonaterra Selected Research

Gabriel A Bonaterra Research Topics

Disease

9	Inflammation (Inflammations) 03/2023 - 01/2005
6	Atherosclerotic Plaque (Atheroma) 01/2023 - 02/2017
5	Atherosclerosis 01/2023 - 06/2010
5	Neoplasms (Cancer) 11/2022 - 09/2006
4	Pathologic Constriction (Stenosis) 01/2023 - 12/2012
4	Astrocytoma (Pilocytic Astrocytoma) 05/2019 - 02/2016
4	Oligodendroglioma 05/2019 - 02/2016
3	Glioblastoma (Glioblastoma Multiforme) 04/2019 - 04/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2020 - 02/2007
2	Carcinoma (Carcinomatosis) 03/2014 - 12/2013
2	Hepatocellular Carcinoma (Hepatoma) 12/2007 - 09/2006
1	Adenocarcinoma 03/2023
1	Cachexia 03/2023
1	Wounds and Injuries (Trauma) 01/2022
1	Cough 01/2020
1	Hypercholesterolemia 01/2020
1	Pain (Aches) 05/2019
1	Infections 06/2018
1	Sepsis (Septicemia) 03/2017
1	Critical Illness (Critically Ill) 03/2017
1	Mood Disorders (Mood Disorder) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2012
1	Vascular System Injuries 12/2012
1	Body Weight (Weight, Body) 12/2012
1	Acute-Phase Reaction 01/2011
1	Arteriosclerosis 02/2007
1	Experimental Liver Neoplasms 09/2006

Drug/Important Bio-Agent (IBA)

6	CholesterolIBA 01/2023 - 06/2010
6	Cytostatic AgentsIBA 05/2019 - 12/2013
4	Apolipoproteins E (ApoE)IBA 01/2023 - 02/2017
3	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2023 - 01/2019
3	LipidsIBA 01/2023 - 02/2007
3	Growth Differentiation Factor 15IBA 09/2022 - 12/2012
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
3	5-fluorouridineIBA 04/2019 - 12/2013
3	oxidized low density lipoproteinIBA 01/2019 - 02/2007
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 12/2012
2	NucleosidesIBA 04/2019 - 04/2016
2	purineIBA 09/2018 - 04/2016
2	EndotoxinsIBA 06/2018 - 03/2017
2	Fluorouracil (Carac)FDA LinkGeneric 03/2014 - 12/2013
1	Monoamine Oxidase (MAO)IBA 03/2023
1	Harmine (Telepathine)IBA 03/2023
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 03/2023
1	Oxidoreductases (Dehydrogenase)IBA 03/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2023
1	Glutathione (Reduced Glutathione)IBA 11/2022
1	Amino Acids FDA Link 11/2022
1	Oxidants (Oxidizing Agents)IBA 01/2022
1	PhytochemicalsIBA 01/2022
1	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2020
1	Therapeutic UsesIBA 05/2019
1	phorbolIBA 05/2019
1	formycinIBA 04/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2019
1	FormycinsIBA 04/2019
1	phorbol-12-myristateIBA 03/2019
1	Cladribine FDA LinkGeneric 03/2019
1	pyrimidineIBA 09/2018
1	Interleukin-6 (Interleukin 6)IBA 06/2018
1	delta (2,16)-5 alpha- androstadiene- 3,17- diol- 3,17- diacetateIBA 06/2018
1	AntioxidantsIBA 03/2017
1	p38 Mitogen-Activated Protein KinasesIBA 02/2017
1	CytokinesIBA 02/2017
1	ApolipoproteinsIBA 02/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	PropionatesIBA 04/2016
1	trienylIBA 04/2016
1	Caspase 3 (Caspase-3)IBA 03/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2007
1	Scavenger Receptors (Scavenger Receptor)IBA 02/2007
1	Lipopolysaccharide ReceptorsIBA 02/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2007
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2007
1	Superoxide DismutaseIBA 02/2007
1	Angiopoietin-2IBA 09/2006
1	DNA (Deoxyribonucleic Acid)IBA 09/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2006
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2005

Therapy/Procedure

4	Therapeutics 09/2022 - 03/2017
1	Parenteral Nutrition 03/2017